CN110878293A - Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein - Google Patents

Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein Download PDF

Info

Publication number
CN110878293A
CN110878293A CN201911295365.0A CN201911295365A CN110878293A CN 110878293 A CN110878293 A CN 110878293A CN 201911295365 A CN201911295365 A CN 201911295365A CN 110878293 A CN110878293 A CN 110878293A
Authority
CN
China
Prior art keywords
yced
gene
bacillus licheniformis
homologous arm
phy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911295365.0A
Other languages
Chinese (zh)
Other versions
CN110878293B (en
Inventor
马昕
陈守文
蔡冬波
莫非
熊敏
吴晗嘉
廖永庆
饶忆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei University
Original Assignee
Hubei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University filed Critical Hubei University
Priority to CN201911295365.0A priority Critical patent/CN110878293B/en
Publication of CN110878293A publication Critical patent/CN110878293A/en
Application granted granted Critical
Publication of CN110878293B publication Critical patent/CN110878293B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the field of Bacillus licheniformis gene engineering modification and protein high-efficiency expression, and discloses application of Bacillus licheniformis lacking yceD gene in heterologous protein productionyceDSuccessfully obtained the deletion geneyceDBacillus licheniformis WX-02 deltayceDOn the basis, alkaline protease AprE free expression plasmid pHY-AprE, keratinase free expression vector pHY-Ker and neutral protease free expression vector pHY-NprE are transferred. Relative to control strainsThe engineering strain constructed by the invention has obvious effect on improving the enzyme activity of the protease, and the enzyme activity is improved by more than 25%.

Description

Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein
Technical Field
The invention relates to the field of Bacillus licheniformis gene engineering modification and high-efficiency protein expression, in particular to application of Bacillus licheniformis lacking yceD gene in production of heterologous protein, wherein the heterologous protein is mainly alkaline protease, keratinase and neutral protease.
Background
Bacillus is a good host for high-efficiency expression of heterologous proteins, and Bacillus licheniformis is a common host strain for high-efficiency industrial production of heterologous proteins, especially protease at present. The protease is an enzyme preparation product which is most widely applied at present, and is widely applied to the fields of food, medicine, chemical industry, waste treatment and the like. Heterologous protein expression is an effective strategy to increase the expression level of a protein of interest. In recent years, more and more strategies have been developed to increase the level of synthesis of proteins of interest. However, there are many genes related to the synthesis and secretion of exogenous proteins in bacillus licheniformis, and the relationship between protein yield and genes is still unknown, and further research on the way of modifying related genes to obtain high-yield protein engineering bacteria is needed.
YceD is a stress protein in Bacillus licheniformis, and whether the expression level is connected with the expression of a heterologous protein is not resolved and unpredictable. According to the invention, the yceD is knocked out from the bacillus licheniformis, so that the technical effect of improving the yield of heterologous proteins is achieved, and the knocking-out of the yceD is an effective strategy for improving the production level of the heterologous proteins.
Disclosure of Invention
One of the purposes of the invention is to provide the application of Bacillus licheniformis of deletion of yceD gene in the production of heterologous protein, wherein the sequence of the yceD gene is shown in SEQ ID NO. 1.
In order to achieve the purpose, the invention adopts the following technical measures:
the application of the Bacillus licheniformis with deletion of yceD gene in the production of heterologous protein comprises knocking out the yceD gene in the Bacillus licheniformis by using the conventional method of the invention, and then transferring the gene into a heterologous protein expression vector for protein expression, wherein the yceD gene is shown in SEQ ID NO. 1.
In the above-mentioned use, preferably, the heterologous protein is an alkaline protease, a keratinase or a neutral protease;
in the above application, preferably, the bacillus licheniformis is bacillus licheniformis WX-02;
in the above application, preferably, the yceD gene knockout method in Bacillus licheniformis comprises the following steps:
(1) PCR amplifying an upstream homologous arm of the yceD gene and a downstream homologous arm of the yceD gene by taking genome DNA of bacillus licheniformis as a template;
(2) connecting an upstream homologous arm of the yceD gene and a downstream homologous arm of the yceD gene together by overlap extension PCR to form a target gene segment;
(3) carrying out double enzyme digestion on the target gene fragment by using XbaI and BamHI restriction endonucleases to obtain an enzyme digestion gene fragment;
(4) preparing plasmid T2(2) -ori, and carrying out double digestion on the plasmid T2(2) -ori by using XbaI and BamHI restriction enzymes to obtain a linear plasmid fragment;
(5) connecting the enzyme-digested gene fragment obtained in the step (3) with the linear plasmid fragment obtained in the step (4) by using DNA ligase to obtain a knockout plasmid T2(2) -delta yceD;
(6) transferring the knockout plasmid T2(2) -delta yceD into bacillus licheniformis, and screening by taking kanamycin as a screening marker to obtain a positive transformant;
(7) after the positive transformant is subjected to transfer culture for a plurality of times, colony PCR detection is carried out to obtain a positive single-exchange conjugant strain which generates single exchange between the upstream homologous arm of the yceD gene or the downstream homologous arm of the yceD gene and the genome DNA of the Bacillus licheniformis WX-02;
(8) and selecting an upstream homologous arm of the yceD gene and a positive single-exchange binding strain which generates single exchange with the genome DNA of the Bacillus licheniformis WX-02, mixing a downstream homologous arm of the yceD gene and a positive single-exchange binding strain which generates single exchange with the genome DNA of the Bacillus licheniformis WX-02, inoculating the mixture into a culture medium which does not contain kanamycin, and performing transfer culture for several times, and screening by a PCR (polymerase chain reaction) method to obtain the Bacillus licheniformis with the yceD gene knocked out.
In the above applications, preferably, when Bacillus licheniformis lacking the yceD gene is used for the production of an alkaline protease, or a heterologous protein of keratinase or neutral protease, the fermentation medium used has a formulation comprising: 10-20g/L glucose, 5-13g/L soybean peptone, 8-12g/L corn steep liquor, 7-11g/L yeast powder, 8-12g/L sodium chloride and 2-5g/LK2HPO4And 4-8g/L (NH)4)2SO4(ii) a Or 5-10g/L bone peptone, 5-13g/L soybean peptone, 8-12g/L corn steep liquor, 7-11g/L yeast powder, 8-12g/L sodium chloride, 2-5g/L K2HPO4And 4-8g/L (NH)4)2SO4
Compared with the prior art, the invention has the following advantages:
the inventor tries to construct the bacillus licheniformis for knocking out the yceD gene for the first time, successfully obtains a bacillus licheniformis heterologous protein expression host strain lacking the yceD gene, and transfers alkaline protease, keratinase and neutral protease free expression vectors, and fermentation results show that the yceD deletion obviously improves the protein expression level, and compared with corresponding control strains, the yield of the heterologous protein of the bacillus licheniformis constructed by the invention is improved by more than 25%. The invention provides a new strategy for the high-efficiency expression of the bacillus licheniformis protein.
Detailed Description
The technical schemes of the invention are conventional schemes in the field if not particularly stated; the reagents or materials, if not specifically mentioned, are commercially available.
The invention takes three proteins (alkaline protease, keratinase and neutral protease) as examples to illustrate the superiority of the technical scheme of the invention; however, in practice, the method is not limited to these three proteins.
Example 1:
obtaining a yceD gene deletion strain Bacillus licheniformis WX-02 delta yceD:
1. designing upstream homology arm primers (yceD-F1 and yceD-R1) and downstream homology arm primers (yceD-F2 and yceD-R2) of the yceD gene according to the gene sequence of the yceD gene in the genome DNA sequence of the Bacillus licheniformis WX-02; and taking genome DNA of Bacillus licheniformis WX-02 as a template, and respectively carrying out PCR amplification by using an upstream homologous arm primer and a downstream homologous arm primer of the yceD gene to obtain an upstream homologous arm fragment of the yceD gene and a downstream homologous arm fragment of the yceD gene (the upstream homologous arm fragment of the yceD gene is 520bp, and the downstream homologous arm fragment of the yceD gene is 542 bp);
wherein, the sequences of yceD-F1, yceD-R1, yceD-F2 and yceD-R2 are as follows:
yceD-F1:GATCTTTTCTACGAGCTCGAACAAGAACGTCATTTA、
yceD-R1:ATTTCCATTCTTCTCCGTCGTCGTGGGCCTTGGCTG、
yceD-F2:CAGCCAAGGCCCACGACGACGGAGAAGAATGGAAAT、
yceD-R2:GTGGCGGCCGCTCTAGAAAAAGTTTTGGCTGCGGCT;
2. taking an upstream homologous arm of the yceD gene and a downstream homologous arm fragment of the yceD gene as templates, taking an upstream homologous arm primer yceD-F1 and a downstream homologous arm primer yceD-R2 as primers, and connecting the upstream homologous arm of the yceD gene and the downstream homologous arm of the yceD gene together through overlap extension PCR to obtain a target gene fragment;
3. carrying out double enzyme digestion on the target gene fragment in the step 2 by using XbaI and BamHI restriction endonucleases to obtain an enzyme digestion gene fragment;
4. and XbaI and BamHI restriction enzyme are adopted to carry out double enzyme digestion on plasmid T2(2) -ori to obtain a linear plasmid fragment;
5. transferring the ligation product into escherichia coli DH5 α by a calcium chloride conversion method, screening by a culture medium containing kanamycin resistance at 37 ℃, screening to obtain a transformant, and carrying out colony PCR verification on a transformant selection plasmid (the used primers are T2-F and T2-R). if the PCR verification result of the transformant is that an electrophoresis band appears at 1314bp, the construction of a knockout vector is successful, wherein the transformant is a positive transformant (named as knockout vector T2(2) -delta yceD);
6. the knockout vector T2(2) -delta yceD is transferred into Bacillus licheniformis WX-02, screened by a kanamycin-resistant culture medium at 37 ℃, screened to obtain a transformant, and subjected to colony PCR verification on a transformant selection plasmid (the used primers are T2-F and T2-R). If the PCR verification result of the transformant is as follows: an electrophoretic band appeared at 1314bp, demonstrating that: the knockout vector T2(2) - Δ yceD was successfully transferred into Bacillus licheniformis WX-02, at which time the transformant was a positive transformant (i.e., Bacillus licheniformis WX-02 into which the knockout vector T2(2) - Δ yceD was transferred);
wherein the sequences of T2-F and T2-R are:
T2-F:ATGTGATAACTCGGCGTA、
T2-R:GCAAGCAGCAGATTACGC;
7. the positive transformant obtained in the step 6 is subjected to grafting culture for 3 times on a kanamycin-resistant culture medium at the temperature of 45 ℃, each time of culture is 12 hours, colony PCR detection is carried out on a single-crossover strain by taking T2-F and delta yceD-KYR as primers (or taking T2-R and delta yceD-KYF as primers), and a band with the length of 1829bp or 2906bp is amplified, namely the single-crossover strain is proved;
wherein the sequences of the delta yceD-KYF and the delta yceD-KYR are as follows:
ΔyceD-KYF:AGATTTTGGTCGGTCTCG、
ΔyceD-KYR:AATCCGCTGCCGATCGCA;
8. and (3) carrying out mixed inoculation culture on the single-crossover strain with the 1829bp band in the PCR detection obtained in the step (7) and the single-crossover strain with the 2906bp band in the PCR detection obtained in the step (7), carrying out transfer culture for a plurality of times in a culture medium without kanamycin at 37 ℃, and picking up transformants for colony PCR verification (the primers are delta yceD-KYF and delta yceD-KYR). If the PCR verification result of the transformant is as follows: when an electrophoresis strip appears at 2013bp, the gene reversion is indicated, and the transformant is bacillus licheniformis WX-02; when an electrophoresis band appears at 1560bp, the successful knockout of the yceD gene on the genome of WX-02 is shown, and the transformant is a positive transformant. Then, DNA sequencing is carried out on the positive transformant for further verification, and a yceD knockout strain (namely Bacillus licheniformis WX-02 delta yceD) with successful double crossover is obtained.
Example 2:
construction of three foreign protein expression vectors:
preparation of alkaline protease free expression plasmid pHY-AprE:
1. using Bacillus licheniformis WX-02 genome DNA as a template, designing a gene expression frame (shown in SEQ ID NO.2 and comprising a promoter, an aprE gene and a terminator) of a primer aprE-F/aprE-R amplification alkaline protease gene aprE, and obtaining an aprE gene sequence 1740 bp;
2. carrying out enzyme digestion on the obtained aprE gene by adopting EcoRI and XbaI to obtain a double enzyme digestion fragment;
3. carrying out double enzyme digestion on the bacillus expression vector pHY300PLK by adopting EcoRI and XbaI to obtain a double enzyme digestion vector fragment;
4. transferring the ligation product into Escherichia coli DH5 α by a calcium chloride conversion method, screening by a tetracycline resistance-containing culture medium at 37 ℃, screening to obtain a transformant, and carrying out colony PCR verification on a transformant plasmid (primers are pHY-F and pHY-R), if the PCR verification result of the transformant is that an electrophoresis band appears at 1992bp, the construction of the expression vector is successful, wherein the transformant is a positive transformant (named as an expression vector pHY-AprE);
AprE-F CGGAATTCTGATCTCATAAAATAAATGAATAGT
AprE-R GCTCTAGAGGGGTCATCTCTTTCGCGTCGT
pHY-F GTTTATTATCCATACCCTTAC
pHY-R CAGATTTCGTGATGCTTGTC。
preparation of keratinase free expression vector pHY-Ker:
1. using Bacillus licheniformis WX-02 genome DNA as a template, designing a primer Ker-F/Ker-R to amplify a gene cluster sequence (shown in SEQ ID NO.3 and comprising a promoter, a gene and a terminator) of an alkaline protease gene aprE, and obtaining an Ker gene fragment 1713 bp;
2. carrying out enzyme digestion on the obtained aprE gene by adopting EcoRI and XbaI to obtain a double enzyme digestion fragment after enzyme digestion;
3. carrying out double enzyme digestion on the bacillus expression vector pHY300PLK by adopting EcoRI and XbaI to obtain a double enzyme digestion vector fragment;
4. transferring the ligation product into escherichia coli DH5 α by a calcium chloride conversion method, screening by a tetracycline resistance-containing culture medium at 37 ℃, screening to obtain a transformant, and performing colony PCR verification on a transformant selection plasmid (primers are pHY-F and pHY-R), wherein if the PCR verification result of the transformant is that an electrophoresis band appears at 1965bp, the construction of the expression vector is successful, and the transformant is a positive transformant (named as an expression vector pHY-Ker);
Ker-F CGGAATTCTTTACAAACGCAGTTTCGAGGCA
Ker-R GCTCTAGATGATCTCATAAAATAAATGAATAG.
preparation of neutral protease free expression vector pHY-NprE:
1. using Bacillus licheniformis WX-02 genome DNA as a template, designing a gene cluster sequence (shown in SEQ ID NO.4 and comprising a promoter, a gene and a terminator) of an alkaline protease gene aprE amplified by a primer NprE-F/NprE-R, and obtaining an aprE gene fragment 2238 bp;
2. carrying out enzyme digestion on the obtained aprE gene by adopting EcoRI and XbaI to obtain a double enzyme digestion fragment after enzyme digestion;
3. carrying out double enzyme digestion on the bacillus expression vector pHY300PLK by adopting EcoRI and XbaI to obtain a double enzyme digestion vector fragment;
4. transferring the ligation product into escherichia coli DH5 α by a calcium chloride conversion method, screening by a tetracycline resistant culture medium at 37 ℃, screening to obtain a transformant, and carrying out colony PCR verification on a transformant selection plasmid (primers are pHY-F and pHY-R), if the PCR verification result of the transformant is that an electrophoresis band appears at 2490bp, the construction of the expression vector is successful, wherein the transformant is a positive transformant (named as an expression vector pHY-NprE);
NprE-F CGGAATTCATGAAATATCTGTCGAAATGCTG
NprE-R GCTCTAGACCCTTCAAACGGAAAACCGTGG。
example 3:
construction and application of three genetic engineering bacteria for expressing foreign protein:
respectively electrically transferring the alkaline protease free expression plasmid pHY-AprE, the keratinase free expression vector pHY-Ker and the neutral protease free expression vector pHY-NprE into the Bacillus licheniformis WX-02 delta yceD, taking tetracycline resistance as a screening marker, performing colony PCR screening, taking pHY-F and pHY-R as verification primers, and performing PCR verification to obtain a positive transformant, thereby obtaining alkaline protease expression strain Bacillus licheniformis WX-02 delta yceD/pHY-AprE, keratinase expression strain Bacillus licheniformis WX-02 delta yceD/pHY-Ker and neutral protease expression strain Bacillus licheniformis WX-02 delta yceD/pHY-NprE;
in this example, the alkaline protease free expression plasmid pHY-AprE, the keratinase free expression vector pHY-Ker and the neutral protease free expression vector pHY-NprE were electroporated into Bacillus licheniformis WX-02 at the same time, and the genetically engineered alkaline protease expression strain Bacillus licheniformis WX-02/pHY-AprE, the keratinase expression strain Bacillus licheniformis WX-02/pHY-Ker and the neutral protease expression strain Bacillus licheniformis WX-02/pHY-NprE were selected as controls by the same method as described above.
In this example, the above six exogenous protein gene engineering bacteria were inoculated into 15 different fermentation media, respectively, to examine the effect of the different media on the target product, and to verify that bacillus licheniformis lacking the yceD gene could indeed improve the expression level of the exogenous protein. The formulation of the fermentation medium used in 15 is shown in Table 1.
The seed fermentation comprises the following specific steps: activating bacillus licheniformis, namely inoculating 1 percent of the bacillus licheniformis in a glycerol pipe in volume percentage into an LB culture medium containing 5mL, culturing for 12 hours at the temperature of 37 ℃ at 230r/min, and then inoculating the bacterial liquid after the bacterial activation in volume percentage according to the inoculation amount of 1 percent into a seed fermentation culture medium to culture for 10 hours at the temperature of 37 ℃ at 230r/min to obtain the bacterial liquid of seed culture;
the production and fermentation method comprises the following specific steps:
50mL of fermentation medium is filled into a 500mL triangular flask, and then the bacterial liquid (OD 6004.0-5.0) cultured by the seeds is fermented and cultured for 48 hours at the rotating speed of 230r/min and the temperature of 37 ℃ according to the inoculation amount of 2 percent (volume percentage) to obtain the bacterial liquid for producing fermentation.
The formulations of the seed fermentation medium and the fermentation medium described above are the same, as shown in table 1.
TABLE 1
Figure BDA0002320369320000061
Figure BDA0002320369320000071
The other components in the 15 culture media are: 10g/L corn steep liquor, 10g/L yeast powder, 10g/L sodium chloride and 3g/LK2HPO4,6g/L(NH4)2SO4,pH7.0~7.2。
The three protease enzyme activities are determined according to the welfare method described in national standards of the people's republic of China.
One unit of enzyme activity (U) is defined as: under the conditions of certain temperature and certain pH value, the protease liquid hydrolyzes casein within 1min to generate 1 mu g of tyrosine.
Wherein the determination of the standard curve: the standard tyrosine solution was prepared in an isocratic solution (10, 20 … … 80, 90, 100. mu.g/mL) and the reactions described in the above documents were carried out.
The protease activity of the sample is calculated by the formula Ax4 xN/10
A, the microgrammes of tyrosine obtained by calculating the value of a sample at 660nm of a spectrophotometer through a standard curve;
n is the dilution multiple of the protease stock solution;
10-reaction time (min) of protease solution and Casein.
The difference in activity of heterologous proteases in the fermentation broth was calculated according to this method (see table 2).
According to the method, the alkaline protease activity difference in WX-02/pHY-AprE and WX-02 delta yceD/pHY-AprE zymocyte liquid is calculated (see table 2); differences in the activity of keratinase in WX-02/pHY-Ker and WX-02. delta. yceD/pHY-Ker fermenters (see Table 3); the neutral protease activity of WX-02/pHY-NprE and WX-02 Δ yceD/pHY-NprE zymocyte solutions is different (see Table 4).
TABLE 2 Alkallikrein activity statistics
Figure BDA0002320369320000081
TABLE 3 statistics of keratinase activity data
Figure BDA0002320369320000082
Figure BDA0002320369320000091
TABLE 4 Neutroprotease enzyme Activity data statistics
Figure BDA0002320369320000092
Figure BDA0002320369320000101
As can be seen from tables 2-4, under the same fermentation conditions, the protease activity in the fermentation liquor of the Bacillus licheniformis WX-02 delta yceD/pHY-AprE, WX-02 delta yceD/pHY-Ker and WX-02 delta yceD/pHY-NprE is greatly improved by more than 25 percent compared with that of the control bacteria. The gene engineering modification method has important application value in the aspect of improving the production of the heterologous protein of the bacillus licheniformis.
Sequence listing
<110> university of Hubei
<120> application of Bacillus licheniformis with deletion of yceD gene in production of heterologous protein
<160>20
<170>SIPOSequenceListing 1.0
<210>1
<211>582
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
atggcaattt cattagcgaa aggacaaaag atcgatttaa caaaaacaaa tcccggattg 60
tcgaaagtcg tcgtgggcct tggctgggac gtcaatcaat atgacggcgg cgctgatttt 120
gacctggatg cgagcgtgtt tctgctcaat gcagaaggca aatgcgcttc tgaaaaggac 180
tttattttct ataatcagac cgaaggcgca ggcggagctg tcatacatac aggcgataat 240
cgaacaggtg aaggcgaagg agacgatgag caggtaaaaa tcaatttgaa tgcagtgcct 300
gccgacattc aaaagatttc ttttgtgatt acgattcatg aagcggaagc gcgccgccaa 360
aactttggac aggtgtcaaa tgcttatgtt cgcgtgatca atgaagactc gaatgaagag 420
ttaatccgct atgatctggg tgaagatttc tcgattgaaa cagcgctgat cacgggagag 480
ctgtaccgtc acggagaaga atggaaattc tcagcgatcg gctcaggcta tcaaggcgga 540
ctggcgagga tcgccaccga tttcggcctg caggtcggct ga 582
<210>2
<211>1740
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
tgatctcata aaataaatga atagtatttt cataaaatga atcagatgga gcaatctcct 60
gtcattcgcg gccctcggga cctctttccc tgccaggctg aagcggtcta ttcatacttt 120
cgaactgaac atttttctaa aacagttatt aataaccaaa aaattttaaa ttggtcctcc 180
aaaaaaatag gcctaccata taattcattt tttttctata ataaattaac agaataattg 240
gaatagatta tattatcctt ctatttaaat tattctgaat aaagaggagg agagtgagta 300
atgatgagga aaaagagttt ttggcttggg atgctgacgg ccttcatgct cgtgttcacg 360
atggcattca gcgattccgc ttctgctgct caaccggcga aaaatgttga aaaggattat 420
attgtcggat ttaagtcagg agtgaaaacc gcatctgtca aaaaggacat catcaaagag 480
agcggcggaa aagtggacaa gcagtttaga atcatcaacg cggcaaaagc gaagctagac 540
aaagaagcgc ttaaggaagt caaaaatgat ccggatgtcg cttatgtgga agaggatcat 600
gtggcccatg ccttggcgca aaccgttcct tacggcattc ctctcattaa agcggacaaa 660
gtgcaggctc aaggctttaa gggagcgaat gtaaaagtag ccgtcctgga tacaggaatc 720
caagcttctc atccggactt gaacgtagtc ggcggagcaa gctttgtggc tggcgaagct 780
tataacaccg acggcaacgg acacggcaca catgttgccg gtacagtagc tgcgcttgac 840
aatacaacgg gtgtattagg cgttgcgcca agcgtatcct tgtacgcggt taaagtactg 900
aattcaagcg gaagcggatc atacagcggc attgtaagcg gaatcgagtg ggcgacaaca 960
aacggcatgg atgttatcaa tatgagcctt gggggagcat caggctcgac agcgatgaaa 1020
caggcagtcg acaatgcata tgcaaaaggg gttgtcgttg tagctgcagc agggaacagc 1080
ggatcttcag gaaacacgaa tacaattggc tatcctgcga aatacgattc tgtcatcgct 1140
gttggtgcgg tagactctaa cagcaacaga gcttcatttt ccagtgtggg agcagagctt 1200
gaagtcatgg ctcctggcgc aggcgtatac agcacttacc caacgaacac ttatgcaaca 1260
ttgaacggaa cgtcaatggc ttctcctcat gtagcgggag cagcagcttt gatcttgtca 1320
aaacatccga acctttcagc ttcacaagtc cgcaaccgtc tctccagcac ggcgacttat 1380
ttgggaagct ccttctacta tgggaaaggt ctgatcaatg tcgaagctgc cgctcaataa 1440
catattctaa caaatagcat atagaaaaag ctagtgtttt tagcactagc tttttcttca 1500
ttctgatgag ggttgttcaa tattttgaat ccgttccatg atcgtcggat ggccgtattt 1560
aaaaatcttg acgagaaacg gcgggtttgc ctcgctcagc ccggcttttg agagctcttg 1620
aaacgtcgaa accgctgcat cgctgttttg cgtcagttca atcgcatact ggtcagcagc 1680
tttttcctga tgcctcgaaa ctgcgttcgt aaatggagac gacgcgaaag agatgacccc 1740
<210>3
<211>1713
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
tttacaaacg cagtttcgag gcatcaggaa aaagccgctg accagtatgc gattgaactg 60
acgcaaaaca gcgatgcagc ggtttcgacg tttcaagagc tctcaaaagc cgggctgagc 120
gaggcaaacc cgccgtttct cgtcaagatt tttaaatacg gccatccgac gatcatggaa 180
cggattcaaa atattgaaca gtcttcatca gaatgaagaa aaagctagtg ctaaaaacac 240
tagctttttc tatatgctat ttgttagaat atgttattga gcggcagctt cgacattgat 300
cagacctttc ccatagtaga aggagcttcc caaataagtc gccgtgctgg agagacggtt 360
gcggacttgt gaagctgaaa ggttcggatg ttttgacaag atcaaagctg ctgctcccgc 420
tacatgagga gaagccattg acgttccgtt caatgttgca taagtgttcg ttgggtaagt 480
gctgtatacg cctgcgccag gagccatgac ttcaagctct gctcccacac tggaaaatga 540
agctctgttg ctgttagagt ctaccgcgcc aacagcgatg acagaatcgt atttcgcagg 600
atagccaatt gtattcgtgt ttcctgaaga tccgctgttc cctgctgcag ctacaacgac 660
aacccctctt gcatatgcat tgtcgactgc ctgtttcatc gctgtcgagc ctgatgctcc 720
cccaaggctc atattgataa catccatgcc gtttgttgtc gcccactcga ttccgcttac 780
aatgccgctg tatgatccgc ttccgcttga attcagtact ttaaccgcgt acaaggatac 840
gcttggcgca acgcctaata cacccgttgt attgtcaagc gcagctactg taccggcaac 900
atgtgtgccg tgtccgttgc cgtcggtgtt ataagcttcg ccagccacaa agcttgctcc 960
gccgactacg ttcaagtccg gatgagaagc ttggattcct gtatccagga cggctacttt 1020
tacattcgct cccttaaagc cttgagcctg cactttgtcc gctttaatga gaggaatgcc 1080
gtaaggaacg gtttgcgcca aggcatgggc cacatgatcc tcttccacat aagcgacatc 1140
cggatcattt ttgacttcct taagcgcttc tttgtctagc ttcgcttttg ccgcgttgat 1200
gattctaaac tgcttgtcca cttttccgcc gctctctttg atgatgtcct ttttgacaga 1260
tgcggttttc actcctgact taaatccgac aatataatcc ttttcaacat ttttcgccgg 1320
ttgagcagca gaagcggaat cgctgaatgc catcgtgaac acgagcatga aggccgtcag 1380
catcccaagc caaaaactct ttttcctcat cattactcac tctcctcctc tttattcaga 1440
ataatttaaa tagaaggata atataatcta ttccaattat tctgttaatt tattatagaa 1500
aaaaaatgaa ttatatggta ggcctatttt tttggaggac caatttaaaa ttttttggtt 1560
attaataact gttttagaaa aatgttcagt tcgaaagtat gaatagaccg cttcagcctg 1620
gcagggaaag aggtcccgag ggccgcgaat gacaggagat tgctccatct gattcatttt 1680
atgaaaatac tattcattta ttttatgaga tca 1713
<210>4
<211>2238
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
atgaaatatc tgtcgaaatg ctgaataaaa tgactgaaaa tctctgacat ctgtaacaat 60
cctttacgtt tattaaggcc tcacccgttt agacaaccgg cattcaaaaa agttttaaag 120
atcttaacat ttttccccta tcatttttcc cgtcttcatt tgtcattttt tccagaaaaa 180
atcgcgtcat tcgactcatg tctaatccaa cacgtgtctc tcggcttatc ccctgacacc 240
gcccgccgac agcccgcatg ggacgattct atcaattcag ccgcggagtc tagttttata 300
ttgcagaatg cgagattgct ggtttattat aacaatataa gttttcatta ttttcaaaaa 360
gggggattta ttgtgggttt aggtaagaaa ttgtctgttg ctgtcgccgc ttcctttatg 420
agtttaacca tcagtctgcc gggtgttcag gccgctgaga atcctcagct taaagaaaac 480
ctgacgaatt ttgtaccgaa gcattctttg gtgcaatcag aattgccttc tgtcagtgac 540
aaagctatca agcaatactt gaaacaaaac ggcaaagtct ttaaaggcaa tccttctgaa 600
agattgaagc tgattgacca aacgaccgat gatctcggct acaagcactt ccgttatgtg 660
cctgtcgtaa acggtgtgcc tgtgaaagac tctcaagtca ttattcacgt cgataaatcc720
aacaacgtct atgcgattaa cggtgaatta aacaacgatg tttccgccaa aacggcaaac 780
agcaaaaaaa tatctgcaaa tcaggcgctg gatcatgctt ataaagcgat cggcaaatca 840
cctgaagccg tttctaacgg aaccgttgca aacaaaaaca aagccgagct gaaagcagca 900
gccacaaaag acggcaaata ccgcctcgcc tatgatgtaa ccatccgcta catcgaaccg 960
gaacctgcaa actgggaagt aaccgttgat gcggaaacag gaaaaatcct gaaaaagcaa 1020
aacaaagtgg agcatgccgc cacaaccgga acaggtacga ctcttaaagg aaaaacggtc 1080
tcattaaata tttcttctga aagcggcaaa tatgtgctgc gcgatctttc taaacctacc 1140
ggaacacaaa ttattacgta cgatctgcaa aaccgcgagt ataacctgcc gggcacactc 1200
gtatccagca ccacaaacca gtttacaact tcttctcagc gcgctgccgt tgatgcgcat 1260
tacaacctcg gcaaagtgta tgattatttc tatcagaagt ttaatcgcaa cagctacgac 1320
aataaaggcg gcaagatcgt atcctccgtt cattacggca gcagatacaa taacgcagcc 1380
tggatcggcg accaaatgat ttacggtgac ggcgacggtt cattcttctc acctctttcc 1440
ggttcaatgg acgtaaccgc tcatgaaatg acacatggcg ttacacagga aacagccaac 1500
ctgaactacg aaaatcagcc gggcgcttta aacgaatcct tctctgatgt attcgggtac 1560
ttcaacgata ctgaggactg ggatatcggt gaagatatta cggtcagcca gccggctctc 1620
cgcagcttat ccaatccgac aaaatacgga cagcctgata atttcaaaaa ttacaaaaac 1680
cttccgaaca ctgatgccgg cgactacggc ggcgtgcata caaacagcgg aatcccgaac 1740
aaagccgctt acaatacgat tacaaaaatc ggcgtgaaca aagcggagca gatttactat 1800
cgtgctctga cggtatacct cactccgtca tcaactttta aagatgcaaa agccgctttg 1860
attcaatctg cgcgggacct ttacggctct caagatgctg caagcgtaga agctgcctgg 1920
aatgcagtcg gattgtaaac aagaaaagag accggaaatc cggtctcttt tttatatcta 1980
aaaacatttc acagtggctt caccatgatc atatatgtct tttcccgatc gtctttttca 2040
agcttcagct gttcaaagcc gcactggctt aaaaacaaca cccattcctg cctggcaagg 2100
ggaacggctg taaacatcgc tttatgctcc gctctcagcc ggccggcaat ctcttcaatg 2160
accgcgcgcc cgattccttt ctcttttgcc tccggagcga cggccacagt tccgagccac 2220
ggttttccgt ttgaaggg 2238
<210>5
<211>36
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
gatcttttct acgagctcga acaagaacgt cattta 36
<210>6
<211>36
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
atttccattc ttctccgtcg tcgtgggcct tggctg 36
<210>7
<211>36
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
cagccaaggc ccacgacgac ggagaagaat ggaaat 36
<210>8
<211>36
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
gtggcggccg ctctagaaaa agttttggct gcggct 36
<210>9
<211>18
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>9
atgtgataac tcggcgta 18
<210>10
<211>18
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>10
gcaagcagca gattacgc 18
<210>11
<211>18
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>11
agattttggt cggtctcg 18
<210>12
<211>18
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>12
aatccgctgc cgatcgca 18
<210>13
<211>33
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>13
cggaattctg atctcataaa ataaatgaat agt 33
<210>14
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>14
gctctagagg ggtcatctct ttcgcgtcgt 30
<210>15
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>15
gtttattatc cataccctta c 21
<210>16
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>16
cagatttcgt gatgcttgtc 20
<210>17
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>17
cggaattctt tacaaacgca gtttcgaggc a 31
<210>18
<211>32
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>18
gctctagatg atctcataaa ataaatgaat ag 32
<210>19
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>19
cggaattcat gaaatatctg tcgaaatgct g 31
<210>20
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>20
gctctagacc cttcaaacgg aaaaccgtgg 30

Claims (5)

1. The application of Bacillus licheniformis of deletion yceD gene in the production of heterologous protein, wherein the yceD gene is shown in SEQ ID No. 1.
2. The use according to claim 1, wherein the heterologous protein is an alkaline protease, a keratinase or a neutral protease.
3. The use of claim 1, wherein the bacillus licheniformis is bacillus licheniformis WX-02.
4. The use according to claim 1, in a method of knockout of the yceD gene in bacillus licheniformis, comprising the steps of:
(1) PCR amplifying an upstream homologous arm of the yceD gene and a downstream homologous arm of the yceD gene by taking genome DNA of bacillus licheniformis as a template;
(2) connecting an upstream homologous arm of the yceD gene and a downstream homologous arm of the yceD gene together by overlap extension PCR to form a target gene segment;
(3) carrying out double enzyme digestion on the target gene fragment by using XbaI and BamHI restriction endonucleases to obtain an enzyme digestion gene fragment;
(4) preparing plasmid T2(2) -ori, and carrying out double digestion on the plasmid T2(2) -ori by using XbaI and BamHI restriction enzymes to obtain a linear plasmid fragment;
(5) connecting the enzyme-digested gene fragment obtained in the step (3) with the linear plasmid fragment obtained in the step (4) by using DNA ligase to obtain a knockout plasmid T2(2) -delta yceD;
(6) transferring the knockout plasmid T2(2) -delta yceD into bacillus licheniformis, and screening by taking kanamycin as a screening marker to obtain a positive transformant;
(7) after the positive transformant is subjected to transfer culture for a plurality of times, colony PCR detection is carried out to obtain a positive single-exchange conjugant strain which generates single exchange between the upstream homologous arm of the yceD gene or the downstream homologous arm of the yceD gene and the genome DNA of the Bacillus licheniformis WX-02;
(8) and selecting an upstream homologous arm of the yceD gene and a positive single-exchange binding strain which generates single exchange with the genome DNA of the Bacillus licheniformis WX-02, mixing a downstream homologous arm of the yceD gene and a positive single-exchange binding strain which generates single exchange with the genome DNA of the Bacillus licheniformis WX-02, inoculating the mixture into a culture medium which does not contain kanamycin, and performing transfer culture for several times, and screening by a PCR (polymerase chain reaction) method to obtain the Bacillus licheniformis with the yceD gene knocked out.
5. Use according to claim 2, when using Bacillus licheniformis lacking the yceD gene for the production of heterologous proteins of alkaline protease, or keratinase or neutral protease, the fermentation medium used has a formulation comprising: 10-20g/L glucose, 5-13g/L soybean peptone, 8-12g/L corn steep liquor, 7-11g/L yeast powder, 8-12g/L sodium chloride, 2-5g/L K2HPO4And 4-8g/L (NH)4)2SO4(ii) a Or 5-10g/L bone peptone, 5-13g/L soybean peptone, 8-12g/L corn steep liquor, 7-11g/L yeast powder, 8-12g/L sodium chloride, 2-5g/L K2HPO4And 4-8g/L (NH)4)2SO4
CN201911295365.0A 2019-12-16 2019-12-16 Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein Active CN110878293B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911295365.0A CN110878293B (en) 2019-12-16 2019-12-16 Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911295365.0A CN110878293B (en) 2019-12-16 2019-12-16 Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein

Publications (2)

Publication Number Publication Date
CN110878293A true CN110878293A (en) 2020-03-13
CN110878293B CN110878293B (en) 2021-08-27

Family

ID=69731373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911295365.0A Active CN110878293B (en) 2019-12-16 2019-12-16 Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein

Country Status (1)

Country Link
CN (1) CN110878293B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058606A (en) * 2021-10-11 2022-02-18 湖北大学 Application of bacillus licheniformis with deleted xpt gene in production of heterologous protein

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013091A1 (en) * 1997-09-12 1999-03-18 The Board Of Regents Of The University Of Oklahoma Fusion protein systems
CN103276007A (en) * 2013-06-19 2013-09-04 江南大学 New strategy for achieving secretion expression of heterogeneous protein by using non-classical secretion proteins
CN105602925A (en) * 2016-01-26 2016-05-25 中国科学院天津工业生物技术研究所 Non-classical secretory protein and application thereof to protein secretory expression
US20170275596A1 (en) * 2016-03-28 2017-09-28 Technion Research & Development Foundation Ltd. Composition and method for treating androgen-dependent disorders
CN109182240A (en) * 2018-09-18 2019-01-11 绿康生化股份有限公司 The B. licheniformis strain and construction method of knockout phoP gene and application
CN110637082A (en) * 2017-01-04 2019-12-31 诺维信生物农业公司 Bacillus isolate and uses thereof
CN110904174A (en) * 2019-12-16 2020-03-24 湖北大学 Application of bacillus licheniformis with deletion of leucine dehydrogenase gene in production of heterologous protein

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013091A1 (en) * 1997-09-12 1999-03-18 The Board Of Regents Of The University Of Oklahoma Fusion protein systems
CN103276007A (en) * 2013-06-19 2013-09-04 江南大学 New strategy for achieving secretion expression of heterogeneous protein by using non-classical secretion proteins
CN105602925A (en) * 2016-01-26 2016-05-25 中国科学院天津工业生物技术研究所 Non-classical secretory protein and application thereof to protein secretory expression
US20170275596A1 (en) * 2016-03-28 2017-09-28 Technion Research & Development Foundation Ltd. Composition and method for treating androgen-dependent disorders
CN110637082A (en) * 2017-01-04 2019-12-31 诺维信生物农业公司 Bacillus isolate and uses thereof
CN109182240A (en) * 2018-09-18 2019-01-11 绿康生化股份有限公司 The B. licheniformis strain and construction method of knockout phoP gene and application
CN110904174A (en) * 2019-12-16 2020-03-24 湖北大学 Application of bacillus licheniformis with deletion of leucine dehydrogenase gene in production of heterologous protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHAO,D.等: "Bacillus paralicheniformis strain FA6 chromosome, complete genome", 《GENBANK》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114058606A (en) * 2021-10-11 2022-02-18 湖北大学 Application of bacillus licheniformis with deleted xpt gene in production of heterologous protein
CN114058606B (en) * 2021-10-11 2023-04-25 湖北大学 Application of bacillus licheniformis with xpt gene deleted in heterologous protein production

Also Published As

Publication number Publication date
CN110878293B (en) 2021-08-27

Similar Documents

Publication Publication Date Title
CN107400677B (en) Bacillus licheniformis genome editing vector based on CRISPR-Cas9 system and preparation method thereof
CN110904174B (en) Application of bacillus licheniformis with deletion of leucine dehydrogenase gene in production of heterologous protein
CN112522173B (en) Engineering bacterium for producing heterologous alkaline protease and construction method thereof
CN111926013B (en) Promoter suitable for bacillus licheniformis and application thereof in high-efficiency expression of target product
CN111549018B (en) Protease mutant with improved thermal stability as well as coding gene and application thereof
CN110607320A (en) Plant genome directed base editing framework vector and application thereof
CN113699128B (en) Method for producing nicotinamide phosphoribosyl transferase by fermentation
CN108441462B (en) Bacillus subtilis and preparation method thereof
CN114958897B (en) Construction method of bacillus subtilis capable of efficiently expressing feed low-temperature keratinase
CN113913357B (en) Chassis strain for producing alkaline protease and construction method and application thereof
CN110878293B (en) Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein
CN114107146A (en) Construction method and application of resistance-marker-free auxotrophic bacillus subtilis
CN111117942B (en) Genetic engineering bacterium for producing lincomycin and construction method and application thereof
CN111363714B (en) Construction method of food-grade streptococcus thermophilus expression vector
CN111254106B (en) Food-grade streptococcus thermophilus expression system and application thereof in yoghourt preparation
CN114058606B (en) Application of bacillus licheniformis with xpt gene deleted in heterologous protein production
CN115074347A (en) Feed additive containing keratinase mutant and bile acid and application thereof
CN114774396A (en) Keratinase mutant, compound preparation of keratinase mutant and bile acid and application of compound preparation in additive
CN107475140B (en) Recombinant pichia pastoris mutant with high pullulanase yield and improved fermentation speed under acidic condition
CN113957072A (en) Short terminator suitable for bacillus licheniformis and application thereof in high-efficiency expression of target product
CN113881618A (en) Recombinant bacillus subtilis for secreting lactocasein, and construction method and application thereof
CN108251447B (en) Plasmid capable of efficiently expressing lipase, construction method and application thereof
CN110643647B (en) Application of bacillus licheniformis glutamate dehydrogenase mutant S277W in poly-gamma-glutamic acid synthesis
CN115160418B (en) Pichia glabra Peptidase secretion protein and application thereof
CN115927267B (en) Bile acid complex enzyme preparation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant